Monopar Therapeutics Inc.

NASDAQ: MNPR · Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.59M -8.4M -10.52M -9.1M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
1.14M 1.9M 1.64M 1.47M
Other Working Capital
2.98M -20.41K 167.52K -86.2K
Other Non-Cash Items
4.55M n/a n/a n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.49M -1.35M 1.65M 317.77K
Operating Cash Flow
-6.4M -7.86M -7.23M -7.32M
Capital Expenditures
n/a 3.00 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-15.32M -7.88M -4.92M n/a
Sales Maturities Of Investments
985.73K 12.81M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-14.34M 4.93M -4.92M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-104.14K -46.97K -76.46K -45.77K
Financial Cash Flow
59.29M 2.03M 32.87K 10.88M
Net Cash Flow
38.55M -920.11K -12.12M 3.57M
Free Cash Flow
-6.4M -7.86M -7.23M -7.32M